SPL 9.20% 9.5¢ starpharma holdings limited

From the BP report summary --. COVID-19 has impacted recruitment...

  1. 2,059 Posts.
    lightbulb Created with Sketch. 302
    From the BP report summary --

    . COVID-19 has impacted recruitment in Phase 2 DEP-trials,
    however sites have reinitiated
    recruitment (London sites a bit slower than regional UK sites) and at this
    stage results from all the trials are expected within the next 6-7 months,
    which would serve as significant re-rating catalysts for the stock.

    I would suggest this info has come from SPL HQ
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.